Targeting Krüppel-like factor 5 (KLF5) for cancer therapy

Yu Gao, Ye Ding, Haiying Chen, Haijun Chen, Jia Zhou

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Krüppel-like factor 5 (KLF5) belongs to a family of zinc-finger-containing transcription factors which are involved in regulating expression of a wide range of genes, thereby affecting diverse cellular functions. The activities of KLF5 are regulated by multiple signaling pathways including Wnt, Ras, TGFβ, Hippo, Notch, retinoid acid receptor, and hormone receptors. The expression of KLF5 is frequently abnormal in human cancers and the functions of KLF5 are context dependent. Accumulating evidence suggests that KLF5 represents a novel therapeutic target for cancer therapy. In this review, we discuss the potential biological functions of KLF5 associated with several key signaling pathways that are relevant to cancer as well as the involvement of KLF5 in various human cancers. We also describe the progress in the discovery and development of small molecules targeting KLF5 as potential therapeutics that may benefit cancer patients. The challenges and future research directions on the drug discovery of KLF5 ligands are also presented.

Original languageEnglish (US)
Pages (from-to)699-713
Number of pages15
JournalCurrent Topics in Medicinal Chemistry
Volume15
Issue number8
StatePublished - 2015

Fingerprint

Neoplasms
Therapeutics
Wnt Signaling Pathway
Zinc Fingers
Retinoids
Drug Discovery
Transcription Factors
Hormones
Ligands
Acids
Genes
Direction compound

Keywords

  • Cancer therapeutics
  • Drug discovery
  • KLF5 ligands
  • Krüppel-like factor 5 (KLF5)
  • Signaling pathways
  • Transcription factors

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Targeting Krüppel-like factor 5 (KLF5) for cancer therapy. / Gao, Yu; Ding, Ye; Chen, Haiying; Chen, Haijun; Zhou, Jia.

In: Current Topics in Medicinal Chemistry, Vol. 15, No. 8, 2015, p. 699-713.

Research output: Contribution to journalArticle

Gao, Y, Ding, Y, Chen, H, Chen, H & Zhou, J 2015, 'Targeting Krüppel-like factor 5 (KLF5) for cancer therapy', Current Topics in Medicinal Chemistry, vol. 15, no. 8, pp. 699-713.
Gao, Yu ; Ding, Ye ; Chen, Haiying ; Chen, Haijun ; Zhou, Jia. / Targeting Krüppel-like factor 5 (KLF5) for cancer therapy. In: Current Topics in Medicinal Chemistry. 2015 ; Vol. 15, No. 8. pp. 699-713.
@article{677cf75561ae42dcb575227125964fe7,
title = "Targeting Kr{\"u}ppel-like factor 5 (KLF5) for cancer therapy",
abstract = "Kr{\"u}ppel-like factor 5 (KLF5) belongs to a family of zinc-finger-containing transcription factors which are involved in regulating expression of a wide range of genes, thereby affecting diverse cellular functions. The activities of KLF5 are regulated by multiple signaling pathways including Wnt, Ras, TGFβ, Hippo, Notch, retinoid acid receptor, and hormone receptors. The expression of KLF5 is frequently abnormal in human cancers and the functions of KLF5 are context dependent. Accumulating evidence suggests that KLF5 represents a novel therapeutic target for cancer therapy. In this review, we discuss the potential biological functions of KLF5 associated with several key signaling pathways that are relevant to cancer as well as the involvement of KLF5 in various human cancers. We also describe the progress in the discovery and development of small molecules targeting KLF5 as potential therapeutics that may benefit cancer patients. The challenges and future research directions on the drug discovery of KLF5 ligands are also presented.",
keywords = "Cancer therapeutics, Drug discovery, KLF5 ligands, Kr{\"u}ppel-like factor 5 (KLF5), Signaling pathways, Transcription factors",
author = "Yu Gao and Ye Ding and Haiying Chen and Haijun Chen and Jia Zhou",
year = "2015",
language = "English (US)",
volume = "15",
pages = "699--713",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Targeting Krüppel-like factor 5 (KLF5) for cancer therapy

AU - Gao, Yu

AU - Ding, Ye

AU - Chen, Haiying

AU - Chen, Haijun

AU - Zhou, Jia

PY - 2015

Y1 - 2015

N2 - Krüppel-like factor 5 (KLF5) belongs to a family of zinc-finger-containing transcription factors which are involved in regulating expression of a wide range of genes, thereby affecting diverse cellular functions. The activities of KLF5 are regulated by multiple signaling pathways including Wnt, Ras, TGFβ, Hippo, Notch, retinoid acid receptor, and hormone receptors. The expression of KLF5 is frequently abnormal in human cancers and the functions of KLF5 are context dependent. Accumulating evidence suggests that KLF5 represents a novel therapeutic target for cancer therapy. In this review, we discuss the potential biological functions of KLF5 associated with several key signaling pathways that are relevant to cancer as well as the involvement of KLF5 in various human cancers. We also describe the progress in the discovery and development of small molecules targeting KLF5 as potential therapeutics that may benefit cancer patients. The challenges and future research directions on the drug discovery of KLF5 ligands are also presented.

AB - Krüppel-like factor 5 (KLF5) belongs to a family of zinc-finger-containing transcription factors which are involved in regulating expression of a wide range of genes, thereby affecting diverse cellular functions. The activities of KLF5 are regulated by multiple signaling pathways including Wnt, Ras, TGFβ, Hippo, Notch, retinoid acid receptor, and hormone receptors. The expression of KLF5 is frequently abnormal in human cancers and the functions of KLF5 are context dependent. Accumulating evidence suggests that KLF5 represents a novel therapeutic target for cancer therapy. In this review, we discuss the potential biological functions of KLF5 associated with several key signaling pathways that are relevant to cancer as well as the involvement of KLF5 in various human cancers. We also describe the progress in the discovery and development of small molecules targeting KLF5 as potential therapeutics that may benefit cancer patients. The challenges and future research directions on the drug discovery of KLF5 ligands are also presented.

KW - Cancer therapeutics

KW - Drug discovery

KW - KLF5 ligands

KW - Krüppel-like factor 5 (KLF5)

KW - Signaling pathways

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=84930915706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930915706&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 699

EP - 713

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 8

ER -